Both thrombophilia led to placental tissue thrombosis, impair the placental blood supply, and activate the coagulation cascade as increased thromboxane production and annexin V displacement in the maternal blood circulation or at the feto-maternal interface. This evidence concerns the gene ANXA5 and Rare hereditary thrombophilia.